Short answer
Option Care Health, Inc. (OPCH) filed its Q2 2026 10-Q quarterly report on Jul 29, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $1.4B (up 1.9% year over year) with net income of $54M.
Q2 2026 key financials · XBRL
- Revenue
- $1.4B
- +1.9% YoY · +6.8% QoQ
- Net income
- $54M
- +6.7% YoY · +18.9% QoQ
- Operating margin
- 5.9%
- Gross margin
- 18.5%
- EPS (diluted)
- $0.35
- +12.9% YoY · +20.7% QoQ
Source: XBRL data from the Option Care Health, Inc. (OPCH) Q2 2026 10-Q on SEC EDGAR. USD.
Option Care Health, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $1,442.4M, up 1.9% YoY from $1,416.1M
- Gross margin 18.5% vs 19.0% YoY; operating margin 5.9% vs 5.8%
- Acute therapies best performer, high single-digit growth; chronic portfolio flat
- Cash $193.8M vs $232.6M at December 31; operating cash flow $171.5M
- $167.5M share repurchases; CID headwinds expected to reduce 2026 gross profit by approximately $55M
Risk Factors
- Risk Factors section not provided in submitted excerpt
- Share-repurchase authorization increased from $500 million to $1 billion in January 2026
- May repurchases totaled 7,351,057 shares at $20.41 each
- Remaining repurchase capacity $525,000,993 as of June 30, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Option Care Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.